Introduction
============

Colorectal cancer (CRC) is one of the most common types of gastrointestinal cancer in China ([@b1-ol-0-0-7837]). CRC increased from being the fifth most common cause of mortality in 2000 to the third most common cause in 2015 ([@b2-ol-0-0-7837]). As colonoscopy is not a popular screening method in China, a majority of patients are diagnosed at advanced stages of caner ([@b3-ol-0-0-7837]). In addition, effective treatment protocols for patients following surgery or chemotherapy have not developed successfully ([@b4-ol-0-0-7837],[@b5-ol-0-0-7837]). The patients that are diagnosed at an early-stage CRC have a better prognosis, and the five-year survival rate is \~90% following surgery ([@b6-ol-0-0-7837]). Radical resection has been the primary treatment for early-stage CRC (including stage I--II) ([@b7-ol-0-0-7837]). However, adjuvant chemotherapy has additionally become an important treatment ([@b8-ol-0-0-7837]--[@b10-ol-0-0-7837]). Regardless of whether patients receive adjuvant therapy, dynamic monitoring following surgery is associated with the improved survival rates of patients with early-stage CRC ([@b11-ol-0-0-7837]--[@b13-ol-0-0-7837]). The sensitivity of existing tumor biomarkers \[including carcinoembryonic antigen (CEA), cancer antigen 125 (CA125) and carbohydrate antigen 19-9\] and other tests \[including computed tomography (CT)\] used for monitoring CRC is low ([@b14-ol-0-0-7837]--[@b16-ol-0-0-7837]). Therefore, identifying a highly sensitive clinical biomarker for the detection of CRC is of utmost importance.

Circulating tumor DNA (ctDNA) is fragmented DNA that is released from exfoliated tumor cells into the blood ([@b17-ol-0-0-7837]). ctDNA carries genetic information from the primary tumor and displays the genetic mutations of the tumor, which overcomes the problem of tumor heterogeneity ([@b18-ol-0-0-7837]). CtDNA is additionally used to monitor responses to treatment and to make decisions on further therapy during follow-up visits ([@b19-ol-0-0-7837]--[@b23-ol-0-0-7837]). Previous studies have revealed that mutations in plasma ctDNA and tumor biopsies were similar for patients with early breast cancer and CRC, and the majority of patients (89%) with driver mutations detected in ctDNA would recur 2--4 weeks postoperatively ([@b24-ol-0-0-7837],[@b25-ol-0-0-7837]).

As a noninvasive detection method, ctDNA as a marker reveals distinct advantages in patients with advanced cancer over other detection methods. However, using ctDNA analysis to monitor therapy is a less sensitive method for patients in the early stages of cancer, which is likely as early-stage tumors release only a few DNA fragments into the blood ([@b26-ol-0-0-7837]). However, other sequencing methods additionally have problems that limit early detection ([@b17-ol-0-0-7837],[@b27-ol-0-0-7837]). In the present study, next generation sequencing (NGS) technology was used to reveal significant associations between changes in ctDNA and different stages of CRC progression in order to examine the value of ctDNA in the clinical diagnosis and treatment of patients with CRC.

Materials and methods
=====================

### Ethics statement

The present study was approved by the Shenzhen People\'s Hospital Ethics Committee, and the protocols were performed in accordance with the approved guidelines ([@b28-ol-0-0-7837]). Written informed consent was obtained from each patient for the use of blood and tumor tissues with the approval of the Shenzhen People\'s Hospital Ethics Committee (Shenzen, China). All samples and clinical data used in the present study were double-blind.

### Patients and collection of clinical samples

The present study recruited 11 patients with primary CRC who underwent radical resection in the Department of Gastrointestinal Surgery at the Shenzhen People\'s Hospital from September 2016 to April 2017. Exclusion criteria: i) Pregnant or lactating women; ii) patients who had received prior treatment with a MEK inhibitor, and iii) a history of clinically significant interstitial lung disease or pneumonitis. Tumor tissues were collected during surgery, quickly frozen in liquid nitrogen and stored at −80°C. Blood samples (20 ml) for ctDNA and CEA analysis were collected from 4--10 weeks postoperatively, with serial twice-monthly blood sample collection, which lasted for up to six months ([Fig. 1](#f1-ol-0-0-7837){ref-type="fig"}). Adjuvant chemotherapy was used at the discretion of the treating clinician, who was blinded to the ctDNA results. As per protocol, follow-up included a twice-monthly clinical review, detection of CEA levels and CT imaging for six months. Subsequently, follow-up visits were performed according to the standard of care at participating institutions, which included three-month and six-month CT visits for two years.

### DNA extraction and sequencing

Tumor DNA was isolated from surgically resected CRC specimens. Blood samples were collected in tubes containing EDTA and centrifuged at 1,600 × g for 10 min at 4°C within 2 h of collection. Peripheral blood lymphocyte (PBL) debris was stored at −20°C until further use. The supernatants were further centrifuged at 10,000 × g for 10 min at 4°C, and plasma was harvested and stored at −80°C until further use. PBL DNA was extracted using the RelaxGene Blood DNA system (Tiangen Biotech Co., Ltd., Beijing, China), and ctDNA was extracted from ≥2 ml of plasma using the QIAamp Circulating Nucleic Acid kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer\'s protocol. DNA was quantified using the Qubit 2.0 fluorometer and the Qubit dsDNA HS Assay kit (Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the manufacturer\'s protocol.

DNA was collected from PBLs and was sheared using the enzyme dsDNA Fragmentase (New England BioLabs, Inc., Ipswich, MA, USA). Size selection of the DNA fragments (150--250 bp) was then performed using Ampure XP beads (Beckman Coulter, Inc., Brea, CA, USA), which has the additional benefits of higher recovery and greater speed. DNA fragments and ctDNA were used for library construction using the KAPA Library Preparation kit (Kapa Biosystems, Inc., Wilmington, MA, USA) according to the manufacturer\'s protocol. Agencourt AMPure XP beads (Beckman Coulter, Inc., Brea, CA, USA) were used for all the cleanup steps. End repair and 3′-end A-tailing were performed following DNA fragmentation. Notably, T-tailed adapters were used and a 3′dA overhang was added enzymatically onto the fragmented DNA sample. Ligation was performed for 15 min at 20°C. Single-step size selection was performed by adding 50 µl (×1) of PEG/NaCl SPRI Solution buffer (Beckman Coulter, Inc.) to enrich ligated DNA fragments. The ligated fragments were then amplified using 1× KAPA HiFi Hot Start Ready mix (Kapa Biosystems, Inc.) and Pre-LM-PCR Oligos (Kapa Biosystems, Inc.) in 50 µl reactions, and 7--8 PCR cycles were performed depending on the amount of DNA input. The thermocycling conditions were as follows: Initial Denaturation, 98°C for 30 sec; 7--8 cycles at 98°C for 10 sec; 60°C for 10 sec; 68°C for 30 sec, and the final extension at 68°C for 60 sec. The purity and concentration of the DNA fragments were assessed using the Qubit 2.0 fluorometer and the Qubit dsDNA HS Assay kit. Fragment length was determined on a 4200 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA, USA) using the DNA 1000 kit (Agilent Technologies, Inc., Santa Clara, CA, USA). DNA sequencing was then performed on the Illumina NextSeq 500 system according to the manufacturer\'s recommendations at a depth of 7,000x.

### Variant calling and analysis

Sequenced genes and their genebank accession numbers are provided in [Table I](#tI-ol-0-0-7837){ref-type="table"} (Colorectal cancer gene panel, 85 genes). Sequencing data were de-multiplexed and aligned to the hg19 genome (GRch37) using Burrows-Wheeler Aligner ([@b29-ol-0-0-7837]) version 0.7.15-r1140 using default settings. Pileup files for properly paired reads with mapping quality ≥60 were generated using Samtools (<http://www.htslib.org/>) ([@b30-ol-0-0-7837]). Somatic variants call were created using VarScan2 (<http://varscan.sourceforge.net/>) ([@b31-ol-0-0-7837]) \[the minimum read depth at a position=100; the variant allele frequency (VAF) is the proportion of reads at a site which contain the variant allele. VAF threshold ≥0.05; somatic-P-value ≤0.01; strand-filter ≥1; otherwise, default parameters\]. Allele frequencies were calculated for all Q30 bases. Using a custom Python script, previously identified tumor DNA mutations were intersected with a Samtools mpileup file generated for each plasma DNA sample; the number and frequency were then calculated for each mutation. For detection of mutations from plasma DNA without tumor DNA present, a mutation was identified if ≥4 mutant reads were identified in plasma and ≥1 mutant read was identified on each strand. No mutant reads were observed in matched genomic DNA from white blood cells.

### Statistical analysis

A likelihood ratio test was used for comparing the difference of the number of nonsynonymous mutations between cancer stages. P\<0.05 was considered to indicate a statistically significant difference. Analyses were performed using the R (version 3.1.2, <https://www.R-project.org>) ([@b32-ol-0-0-7837]).

Results
=======

### Patient characteristics

A total of 11 patients with CRC were enrolled, including 9 patients with colon cancer and 2 patients with rectal cancer. The cohort included 4 patients with stage I, 3 patients with stage II, 3 patients with stage III and 1 patient with stage IV using a pathological staging system ([@b33-ol-0-0-7837]). CT imaging revealed that 1 patient with CRC had liver metastasis at surgery. A total of 9 patients received postoperative chemotherapy following surgery. In total, 11 primary tumor tissues and 42 plasma samples were collected. Complete information is presented in [Tables II](#tII-ol-0-0-7837){ref-type="table"} and [III](#tIII-ol-0-0-7837){ref-type="table"}.

Somatic mutations in tumor tissue samples. Varscan2 (somatic P-value=0.01, minimum variant frequency=5%, strand filter=true, and otherwise default parameters) was used to detect tumor somatic single nucleotide variants (SNVs) and short insertion/deletion events captured by a panel of 85 genes (0.03% of the human genome; [Table I](#tI-ol-0-0-7837){ref-type="table"}). Within this small target, the number of nonsynonymous mutations detected in tumors ranged from 1 to 15, with a median of 5, including SNVs (59--86%) and small deletions (10--14%; [Fig. 2](#f2-ol-0-0-7837){ref-type="fig"}; [Table IV](#tIV-ol-0-0-7837){ref-type="table"}). The number of nonsynonymous mutations was not associated with the CRC stage (P=0.451). Additionally, it was identified that A\>C\|T\>G transversion occurred most frequently (24 and 41%, respectively), followed by C\>T\|G\>A transition ([Fig. 3](#f3-ol-0-0-7837){ref-type="fig"}).

Different driver gene mutations revealed inter-individual tumor genetic heterogeneity. For example, KRAS mutations in codons 12 and 13 were observed in 3 patients and 1 patient, respectively. Tumor protein p53 (TP53) mutations in exons 5, 7 and 8 were observed in 3, 2 and 2 patients, respectively. A heatmap was constructed in order to demonstrate the somatic mutations occurring in the tumor tissues ([Fig. 4](#f4-ol-0-0-7837){ref-type="fig"}). Different mutation loci and their corresponding mutation rates indicated intratumor genetic heterogeneity, implying tumor evolution ([Fig. 5](#f5-ol-0-0-7837){ref-type="fig"}).

### Somatic mutation detection in preoperative plasma

Next, ctDNA levels in preoperative plasma were examined. At a mean sequencing depth of x\~7,000 (pre-duplication), a custom Python script was used to identify whether somatic tumor mutations were present in preoperative plasma. For a total of 7 patients, at least one mutation in tumor tissue was detected in preoperative plasma, and VAF in plasma ranged from 0.11 to 9.42% ([Fig. 6](#f6-ol-0-0-7837){ref-type="fig"}). For the other 4 patients (H1002, H1005, H1006 and H1010), who were diagnosed with stage II or stage III cancer, no mutations that matched the tumor mutations were detected in the plasma.

### Dynamic monitoring of postoperative patients with CRC using ctDNA

In order to determine prognosis for patients with CRC and decide whether or not to administer adjuvant chemotherapy, ctDNA levels were monitored periodically for six months. Driver gene mutations were detected at low mutation rates in preoperative plasma ctDNA from 7 patients (7/11; 63.6%), whilst no driver mutations were detected in the remaining 4 patients (4/11; 36.4%; patient nos. ID H1002, H1005, H1006 and H1010; see [Table IV](#tIV-ol-0-0-7837){ref-type="table"}).

Following surgery, the number of mutations and the corresponding mutation rate decreased compared with preoperative plasma in postoperative plasma in the majority of patients. Driver mutations were not detected in 6 patients (6/11; 54.5%). To illustrate this, the changes in the percentage of ctDNA and CEA levels in patient H1001 were plotted ([Fig. 7A and B](#f7-ol-0-0-7837){ref-type="fig"}). In patient H1001, the CEA levels initially declined and then increased slowly, but the levels remained in the normal range (\<5 µg/l; [Fig. 7B](#f7-ol-0-0-7837){ref-type="fig"}).

The VAF values for patient H1003 are presented in [Fig. 8A](#f8-ol-0-0-7837){ref-type="fig"}. For patient H1003, the mutation rate of NM_0,011,26113.2 (TP53):c.857A\>G (p.Glu286Gly) in ctDNA increased from 8.95 (preoperation) to 11.32% (post-operation) ([Fig. 8A](#f8-ol-0-0-7837){ref-type="fig"}). Liver metastases were detected in patient H1003 at the time of surgery ([Fig. 8B](#f8-ol-0-0-7837){ref-type="fig"}). Following surgery, patient H1003 received one round of chemotherapy and two rounds of microwave ablation for liver metastases, but treatments were subsequently terminated. The periodic monitoring of plasma ctDNA in patient H1003 revealed an increase in the mutation rate of TP53, and the development of a new mutation, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). NM_006218.3 (PIK3CA):c.1624G\>A (p.Glu542Lys) ([Fig. 8A](#f8-ol-0-0-7837){ref-type="fig"}). In the final ctDNA sample from this patient, the mutation rate of TP53 and PIK3CA reached 71.4 and 19.96%, respectively ([Fig. 8A](#f8-ol-0-0-7837){ref-type="fig"}). Patient H1003 succumbed to mortality six months following surgery. Furthermore, CEA levels were lower compared to the threshold (cut-off, 5 µg/l) in the three tests prior to mortality (2.63, 2.02 and 3.45 µg/l), which was not revealed to be associated with the patient\'s condition. However, the CEA level increased at the time of last sampling (11.12 µg/l; [Fig. 8B](#f8-ol-0-0-7837){ref-type="fig"}). This finding suggests that ctDNA is more sensitive compared with CEA as a biomarker for predication of disease progression.

Discussion
==========

In the present study, somatic mutations in tumor tissues and preoperative plasma were highly associated as represented by the status of KRAS gene. In previous studies, ctDNA detection rates for patients in the early stages of cancer were low ([@b16-ol-0-0-7837],[@b27-ol-0-0-7837],[@b34-ol-0-0-7837]). Detection was improved in the present study by increasing the depth of ctDNA sequencing (\~7,000X), which allowed for the monitoring of ctDNA dynamically to follow disease progression. ctDNA analysis using NGS was demonstrated to be sensitive for monitoring early therapeutic responses of CRC and metastatic breast cancer ([@b35-ol-0-0-7837]). Driver mutations in genes such as TP53, KRAS and adenomatosis polyposis coli tumor suppressor as observed in the 11 patients in the present study, were previously reported in patients with CRC ([@b36-ol-0-0-7837]). These mutations, thus, appear to be useful biomarkers for postoperative monitoring of CRC. As the sample size is relatively small, statistical bias is difficult to avoid.

For patients with early-stage CRC, administration of adjuvant chemotherapy following surgical resection remains controversial. Highly sensitive and specific biomarkers to predict the response to surgery are urgently required. Biomarkers for the early detection of recurrences would also be clinically valuable. In addition to previous research ([@b16-ol-0-0-7837]), the present study indicates that plasma ctDNA analysis has the potential for the detection of the early stages of cancer. Tie *et al* ([@b37-ol-0-0-7837]) demonstrated that ctDNA detection subsequent to stage II ([@b33-ol-0-0-7837]) colon cancer resection provided evidence of residual disease and identified patients at a substantially high risk of recurrence. Similar results were observed in the present study. However, the previous study by Tie *et al* ([@b37-ol-0-0-7837]) made predictions by targeting 15 genes and one single mutation in the ctDNA was selected for further analysis. By contrast, the present study examined preoperative and postoperative ctDNA for a whole spectrum of mutations. By comparison, the present study not only predicted the risk of recurrence, but was indicative of the tumor evolution for patients with cancer recurrence, which increases the current understanding of mechanism underlying recurrence in cancer.

As tumor-specific DNA is only a small fraction of cell-free DNA, ctDNA mutations are difficult to detect in patients with early stage cancer ([@b37-ol-0-0-7837]). For the patients in the present study with no preoperative driver gene mutations, we hypothesized that tumor cells may have invaded the serous layer of the intestinal wall. During the six months of monitoring, no changes were observed in the blood of patients with early-stage cancer. These findings indicate a good surgical outcome consistent with a greater survival of patients with early-stage CRC following surgery ([@b37-ol-0-0-7837],[@b38-ol-0-0-7837]).

With the rapid progression of patients with late-stage cancer, driver mutations may quickly and substantially change in the blood. A high frequency of TP53 somatic mutation was detected in preoperative blood and tumor tissue of patient H1003. One month after surgery, the rate of TP53 mutations increased, which was associated with the presence of liver metastases observed on CT imaging subsequent to surgery. Conversely, decreased VAF of TP53 mutation were observed in all the other patients that did not have metastases following surgery. These results suggest that ctDNA ought to be analyzed in plasma at least every six months following surgery in order to monitor for disease progression in patients with early-stage cancer. Plasma CEA levels of patients with early or even advanced CRC were often below the normal threshold, implying that ctDNA has a higher sensitivity and specificity for detecting CRC compared with conventional CEA analysis.

Sequencing error rates are reported to be \>0.1% in data analysis ([@b39-ol-0-0-7837]). In the present study, the correct mutations were selected by increasing the sequencing depth and a VAF threshold of \<5% was used to filter the mutations detected. According to the tissue mutation results, ctDNA mutations were filtered using a VAF threshold of \<0.1%, which may limit the sensitivity of ctDNA and omit a number of low-frequency mutations. Although the number of patients in the present study is small, it demonstrates the potential of using ctDNA to monitor the medical response and disease progression following surgery. ctDNA analysis will be applied to a greater number of clinical applications in the future.

The authors would like to thank Mr. Liwei Deng and Mr. Cheng Jin for enhancing the diagram and charts. The present study was supported by the grants from the Gastrointestinal Department of Shenzhen People\'s Hospital (grant no. 201601016), the Creative Design Program of Nanshan Shenzhen (grant no. KC2015JSJS0028A) for data collection, and the Special Funds for Future Industries of Shenzhen (grant no. JSGG20160229123927512) for sequencers and reagents. Clinicians of the Shenzhen People\'s Hospital were involved in study design, sample collection, and clinical information collection, while researchers and engineers from HaploX were involved in the study design and sequencing data analysis.

![Patient enrolment and sample collection. Flow chart of patient enrollment and sample collection. CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CT, computed tomography; chemo, chemotherapy.](ol-15-04-4365-g00){#f1-ol-0-0-7837}

![Mutation statistics of tumor samples from 11 patients with colorectal cancer. The y-axis indicates the number of mutations and the x-axis indicates the patient ID. The type of mutations (SNV and INDEL) is indicated in green and orange, respectively. SNV, single nucleotide variants; INDEL, small insertions and deletions.](ol-15-04-4365-g01){#f2-ol-0-0-7837}

![SNV base substitution statistics. Counts are indicated in columns. The base substitution types are indicated in rows, and different subtypes of base substitutions are represented in aquamarine and coral. SNV, single nucleotide variant.](ol-15-04-4365-g02){#f3-ol-0-0-7837}

![Mutation heatmap. Mutation spectrum of tumor tissues from 11 patients with colorectal cancer. The mutation frequencies of genes with high mutation rates among these 11 patients are indicated. The names of the mutated genes are indicated in the y-axis, and the patient no. is shown in the x-axis. The type of mutations, including frame-shift deletion, in-frame deletion, missense, nonsense and frame-shift insertions are represented by the colors blue, yellow, red, orange and pink, respectively.](ol-15-04-4365-g03){#f4-ol-0-0-7837}

![Summary of VAF in 11 tumor cases. Scatter plots of the VAF in tumor tissues from 11 patients with colorectal cancer. The VAF values are indicated in the y-axis, and the patient ID is shown in the x-axis. The vertical line with dots represent the mean ± standard deviation of VAF. VAF, variant allele fraction.](ol-15-04-4365-g04){#f5-ol-0-0-7837}

![VAF in pre-operative plasma from 11 patients with CRC. Scatter plots of VAF in ctDNA of pre-operative plasma from 11 patients with CRC. The patient ID is presented on the x-axis, and the VAF is indicated on the y-axis. The vertical line with dots represent the mean ± standard deviation of the VAF. CRC, colorectal cancer; VAF, variant allele fraction.](ol-15-04-4365-g05){#f6-ol-0-0-7837}

![Dynamic ctDNA monitoring of patient H1001. (A) ctDNA and (B) CEA levels were assessed preoperatively and postoperatively for patient no. H1001. Patient no. H1001 exhibited no recurrence. The number of days following surgery is indicated on the x-axis. (B) The concentration of CEA is indicated on the y-axis. ctDNA, circulating tumor DNA; CEA, carcinoembryonic antigen.](ol-15-04-4365-g06){#f7-ol-0-0-7837}

![Dynamic ctDNA monitoring of patient H1003. (A) ctDNA and CEA levels were assessed pre-operatively and postoperatively for patient H1003. H1003 presented with recurrence during colonoscopy and in contrast-enhanced CT. For patient H1003, the TP53 and PIK3CA mutation rate changes in ctDNA are presented at the indicated times, and compared with CEA. The number of days following surgery is indicated on the x-axis is indicated on the x-axis. The VAF values are indicated on the y-axis. (B) CT images of liver metastases in patient H1003, in whom the level of ctDNA was four times compared with other patients in the study without metastases. Images were captured on October 17th, 2016 (30 days after surgery), November 30th, 2016 (43 days after surgery), December 12th, (55 days after surgery) and February 4th, 2017 (98 days after surgery). CT, computed tomography; ctDNA, circulating tumor DNA; CEA, carcinoembryonic antigen; PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; TP53, tumor protein P53; VAF, variant allele fraction.](ol-15-04-4365-g07){#f8-ol-0-0-7837}

###### 

Colorectal cancer gene panel (85 genes).

  Gene name   GenBank accession number
  ----------- --------------------------
  ABCB1       NM_000927
  AKAP9       NM_005751
  AKT1        NM_005163
  APC         NM_000038
  ARID1A      NM_006015
  ATIC        NM_004044
  ATM         NM_000051
  AXIN2       NM_004655
  BARD1       NM_000465
  BMPR1A      NM_004329
  BRAF        NM_004333
  BRCA1       NM_007294
  BRCA2       NM_000059
  BRIP1       NM_032043
  BUB1        NM_004336
  C8orf34     NM_052958
  CBR3        NM_001236
  CDA         NM_001785
  CDH1        NM_004360
  CHEK2       NM_007194
  CREBBP      NM_004380
  CTNNB1      NM_001904
  CYP19A1     NM_000103
  CYP2D6      NM_000106
  DPYD        NM_000110
  EGFR        NM_005228
  EIF3E       NM_001568
  EPCAM       NM_002354
  ERBB2       NM_004448
  ERBB4       NM_005235
  ERCC1       NM_001983
  FBXW7       NM_018315
  GREM1       NM_013372
  GSTP1       NM_000852
  HRAS        NM_005343
  KDR         NM_002253
  KMT2C       NM_170606
  KMT2D       NM_003482
  KRAS        NM_004985
  MET         NM_000245
  MLH1        NM_000249
  MLH3        NM_014381
  MRE11A      NM_005590
  MSH2        NM_000251
  MSH3        NM_002439
  MSH5        NM_002441
  MSH6        NM_000179
  MTHFR       NM_005957
  MTRR        NM_002454
  MUTYH       NM_012222
  NBN         NM_002485
  NF1         NM_000267
  NRAS        NM_002524
  PALB2       NM_024675
  PIK3CA      NM_006218
  PMS1        NM_000534
  PMS2        NM_000535
  POLD1       NM_002691
  POLE        NM_006231
  PTCH1       NM_000264
  PTEN        NM_000314
  PTPRK       NM_002844
  RAD50       NM_005732
  RAD51C      NM_002876
  RAD51D      NM_002878
  RB1         NM_000321
  RRM1        NM_001033
  RSPO2       NM_178565
  RSPO3       NM_032784
  SLIT1       NM_003061
  SMAD2       NM_005901
  SMAD4       NM_005359
  SOD2        NM_000636
  STK11       NM_000455
  STMN1       NM_005563
  TOP2A       NM_001067
  TP53        NM_000546
  TRRAP       NM_003496
  TUBB3       NM_006086
  TYMP        NM_001953
  TYMS        NM_001071
  UGT1A1      NM_000463
  UMPS        NM_000373
  XPC         NM_004628
  XRCC1       NM_006297

###### 

Clinical characteristics of 11 patients with CRC.

  Patient no.   Sex      Age at surgery (years)   Histology   TNM        Tumor stage   Size of tumor tissue (cm)   Maximum diameter (cm)   Adjuvant chemotherapy at surgery   Family history of cancer
  ------------- -------- ------------------------ ----------- ---------- ------------- --------------------------- ----------------------- ---------------------------------- --------------------------
  H1001         Male     69                       Colon       T4bN0M0    IIC           4.0×3.0×2.0                 4.0                     N                                  N
  H1002         Female   50                       Colon       T2N1aM0    IIIA          2.1×1.5×0.6                 2.1                     Oxaliplatin+5-FU (20 weeks)        N
  H1003         Male     73                       Rectum      T3N2aM1b   IVB           5.5×4.0×0.8                 5.5                     Capecitabine (10 weeks)            Y
  H1004         Female   49                       Rectum      T2N0M0     I             2.0×2.0×0.5                 2.0                     Oxaliplatin+5-FU (2 weeks)         N
                                                                                                                                           Capecitabine (12 weeks)            
  H1005         Female   60                       Colon       T3N1cM0    IIIB          2.2×1.8×1.0                 2.2                     Oxaliplatin (16 weeks)             NA
  H1006         Female   69                       Colon       T1N0M0     I             1.5×1.5×1.0                 1.5                     N                                  Y
  H1007         Male     53                       Colon       T2N0M0     I             4.3×2.5×1.2                 4.3                     Oxaliplatin+5-FU (4 weeks)         N
                                                                                                                                           Capecitabine (18 weeks)            
  H1008         Female   61                       Colon       T1N0M0     I             7.5×4.0×3.5                 7.5                     Capecitabine (18 weeks)            N
  H1009         Male     67                       Colon       T3N0M0     IIA           11.0×4.0×1.2                11                      Capecitabine (18 weeks)            N
  H010          Female   35                       Colon       T3N1aM0    IIIB          3.0×2.5×0.7                 3                       Oxaliplatin+5-FU (20 weeks)        N
  H1011         Female   48                       Colon       T3N0M0     IIA           2.5×4.5×1.5                 4.5                     Capecitabine (24 weeks)            N

N, no; Y, yes; TNM, tumor-node metastasis; 5-FU, fluorouracil; NA, unknown.

###### 

Patient and tumor characteristics.

  Characteristics                Patients (n=11)
  ------------------------------ -----------------
  Age at surgery                 
    Years, median (range)        57.6 (35--73)
  Sex, n (%)                     
    Male                         4 (36.4)
    Female                       7 (63.6)
  Tumor stage, n (%)             
    I                            4 (36.3)
    II                           3 (27.3)
    III                          3 (27.3)
    IV                           1 (9.1)
  Localization, n (%)            
    Colon                        9 (81.8)
    Rectum                       2 (18.2)
  Adjuvant chemotherapy, n (%)   
    Yes                          9 (81.8)
    No                           2 (18.2)
  Family history, n (%)          
    Yes                          2 (18.2)
    No                           8 (72.7)
    NA                           1 (9.1)

NA, unknown.

###### 

Dynamic detection of tumor tissue DNA and serial plasma circulating tumor DNA driver mutations in 11 patients with colorectal cancer.

  Case    Gene      Chromosome   Transcript     Exon     Nucleotide variation   Amino acid variation   Mutation frequency of tumor tissue (%)   Cosmid        Mutation frequency of preoperative plasma (%)   ALT-Depth   Depth   Mutation frequency of 1 month postoperative plasma (%)   ALT-Depth   Depth   Mutation frequency of 3 month postoperative plasma(%)   ALT-Depth   Depth   Mutation frequency of 5 mo postoperative plasma(%)   ALT-Depth   Depth
  ------- --------- ------------ -------------- -------- ---------------------- ---------------------- ---------------------------------------- ------------- ----------------------------------------------- ----------- ------- -------------------------------------------------------- ----------- ------- ------------------------------------------------------- ----------- ------- ---------------------------------------------------- ----------- -------
  H1001   ERBB2     chr17        NM_004448      exon21   c.G2524A               p.V842I                34.81                                    COSM14065     1.26                                            35          2,787   0                                                        0           0       --                                                      --          --      0                                                    0           0
  H1001   APC       chr5         NM_000038      exon6    c.G568T                p.E190X                32.16                                    COSM258874    0.87                                            23          2,653   0                                                        0           0       --                                                      --          --      0                                                    0           0
  H1001   TP53      chr17        NM_000546      exon5    c.G524A                p.R175H                31.4                                     COSM10648     1.02                                            16          1,575   0.46                                                     5           1,081   --                                                      --          --      0                                                    0           0
  H1001   ERBB4     chr2         NM_005235      exon28   c.T3492A               p.N1164K               26.48                                                  1.03                                            33          3,215   0                                                        0           0       --                                                      --          --      0                                                    0           0
  H1001   KRAS      chr12        NM_004985      exon2    c.G35A                 p.G12D                 25.66                                    COSM521       0.44                                            10          2,254   0                                                        0           0       --                                                      --          --      0                                                    0           0
  H1002   TP53      chr17        NM_000546      exon8    c.G818A                p.R273H                81.35                                    COSM10660     0                                               0           0       0                                                        0           0       0.13                                                    3           2,352   0                                                    0           0
  H1002   APC       chr5         NM_000038      exon16   c.G4222T               p.E1408X               80.49                                    COSM18822     0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1002   APC       chr5         NM_000038      exon16   c.T2735A               p.L912X                78.89                                    COSM4167198   0                                               0           0       0.26                                                     2           768     0                                                       0           0       0                                                    0           0
  H1003   TP53      chr17        NM_000546      exon8    c.A857G                p.E286G                61.08                                    COSM43565     8.95                                            233         2,602   11.32                                                    124         1,100   42.39                                                   993         2,342   71.4                                                 1,990       2,787
  H1003   MLH3      chr14        NM_014381      exon2    c.G1163A               p.S388N                7.23                                                   0.11                                            3           2,790   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1003   KMT2D     chr12        NM_003482      exon31   c.G7489A               p.A2497T               5.17                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1003   PIK3CA    chr3         NM_006218      exon9    c.G1624A               p.E542K                0                                        COSM760       0                                               0           0       0                                                        0           0       12.66                                                   195         1,542   19.96                                                505         2,532
  H1003   APC       chr5         NM_000038      exon6    c.617delC              p.T206fs               68.83                                                  8.58                                            159         1,854   15.69                                                    96          612     0                                                       0           0       76.53                                                2,045       2,672
  H1003   PTEN      chr10        NM_001304717   exon1    c.19_21del             p.7_7del               5.76                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   CTNNB1    chr3         NM_001904      exon3    c.A121G                p.T41A                 65.85                                    COSM5664      0.27                                            9           3,292   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   BRCA2     chr13        NM_000059      exon10   c.A832G                p.S278G                33.18                                                  0.22                                            6           2,735   0.53                                                     6           1,125   0                                                       0           0       0                                                    0           0
  H1004   PIK3CA    chr3         NM_006218      exon2    c.A331G                p.K111E                31.66                                    COSM13570     0.81                                            25          3,076   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   KRAS      chr12        NM_004985      exon2    c.G38A                 p.G13D                 30.32                                    COSM532       1                                               19          1,897   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   BRCA2     chr13        NM_000059      exon13   c.C7006T               p.R2336C               30.17                                    COSM432312    0.56                                            15          2,702   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   FZR1      chr19        NM_016263      exon7    c.C542T                p.A181V                28.37                                                  0.33                                            9           2,733   0.21                                                     2           937     0                                                       0           0       0                                                    0           0
  H1004   SLIT1     chr10        NM_003061      exon11   c.G1054A               p.A352T                27.5                                                   0                                               0           0       0                                                        0           0       0.27                                                    2           740     0                                                    0           0
  H1004   CYP19A1   chr15        NM_000103      exon10   c.C1285T               p.P429S                27.34                                                  0.41                                            10          2,458   0.34                                                     4           1,178   0.52                                                    6           1,163   0                                                    0           0
  H1004   KMT2D     chr12        NM_003482      exon11   c.C3868T               p.R1290W               22.82                                    COSM4042398   0.59                                            12          2,031   0                                                        0           0       0.22                                                    2           913     0                                                    0           0
  H1004   KMT2B     chr19        NM_014727      exon28   c.T6737G               p.V2246G               7.95                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   KMT2B     chr19        NM_014727      exon28   c.T6746G               p.V2249G               5.39                                                   0.51                                            3           587     0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   ARID1A    chr1         NM_006015      exon1    c.433delC              p.P145fs               25.28                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1004   AKAP9     chr7         NM_005751      exon19   c.5010_5013del         p.G1670fs              22.1                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1005   EPCAM     chr2         NM_002354      exon1    c.T25G                 p.F9V                  6.32                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       --                                                   --          --
  H1006   RB1       chr13        NM_000321      exon1    c.A13C                 p.T5P                  10.03                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1006   KMT2B     chr19        NM_014727      exon28   c.T6746G               p.V2249G               5.22                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1006   ARID1A    chr1         NM_006015      exon1    c.A653C                p.N218T                5.07                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1006   APC       chr5         NM_000038      exon16   c.4217_4218del         p.Q1406fs              49.86                                    COSM5007948   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1006   TP53      chr17        NM_000546      exon7    c.749_756del           p.P250fs               36.1                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   SMAD4     chr18        NM_005359      exon9    c.G988C                p.E330Q                41.96                                    COSM14240     0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   TP53      chr17        NM_000546      exon5    c.G473A                p.R158H                40.38                                    COSM10690     0.21                                            2           972     0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   PIK3CA    chr3         NM_006218      exon5    c.A1034T               p.N345I                34.47                                    COSM94978     0                                               0           0       0                                                        0           0       0                                                       0           0       0.48                                                 5           1,058
  H1007   FBXW7     chr4         NM_018315      exon8    c.C1018T               p.H340Y                32.41                                    COSM28798     0.28                                            3           1,086   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   KRAS      chr12        NM_004985      exon2    c.G35T                 p.G12V                 26.5                                     COSM520       0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   CDH1      chr16        NM_004360      exon9    c.G1259A               p.G420D                18.71                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   ATM       chr11        NM_000051      exon17   c.T2570G               p.L857R                14.45                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1007   SMAD2     chr18        NM_005901      exon9    c.1009_1024del         p.R337fs               29.56                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1008   KRAS      chr12        NM_004985      exon3    c.A183T                p.Q61H                 79.42                                    COSM555       3.26                                            52          1,593   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1008   SMAD4     chr18        NM_005359      exon12   c.T1619G               p.L540R                68.95                                    COSM14165     0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1008   UGT1A1    chr2         NM_000463      exon1    c.G323A                p.R108H                36.8                                     COSM1018132   0.46                                            7           1,508   0.2                                                      4           1,992   0.17                                                    3           1,756   0                                                    0           0
  H1008   ATIC      chr2         NM_004044      exon6    c.G515A                p.R172H                18.27                                    COSM1183927   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1009   KRAS      chr12        NM_004985      exon2    c.G35A                 p.G12D                 33.98                                    COSM521       0.54                                            3           553     0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1009   RB1       chr13        NM_000321      exon1    c.A13C                 p.T5P                  7.94                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1009   ARID1A    chr1         NM_006015      exon1    c.A317C                p.N106T                6.77                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1009   MSH6      chr2         NM_000179      exon1    c.A256C                p.T86P                 5.56                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1009   ARID1A    chr1         NM_006015      exon20   c.5125_5131del         p.L1709fs              21.35                                                  0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1010   KMT2B     chr19        NM_014727      exon1    c.T266G                p.V89G                 7.46                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1010   KMT2B     chr19        NM_014727      exon28   c.T6746G               p.V2249G               6.78                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1010   KMT2D     chr12        NM_003482      exon11   c.T2987G               p.V996G                5.41                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1010   TP53      chr17        NM_000546      exon7    c.715_720del           p.239_240del           11.72                                    COSM45055     0                                               0           0       0                                                        0           0       0.19                                                    3           1,624   0                                                    0           0
  H1010   APC       chr5         NM_000038      exon16   c.2025delA             p.T675fs               7.35                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   TP53      chr17        NM_000546      exon8    c.C844T                p.R282W                43.17                                    COSM10704     0.39                                            6           1,533   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   PIK3CA    chr3         NM_006218      exon5    c.T1035A               p.N345K                40.51                                    COSM754       0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   RB1       chr13        NM_000321      exon1    c.A13C                 p.T5P                  8.73                                                   9.42                                            13          138     0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   TP53      chr17        NM_000546      exon5    c.G404A                p.C135Y                8.28                                     COSM10801     0.19                                            3           1,548   0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   KMT2B     chr19        NM_014727      exon1    c.T248G                p.L83R                 7.96                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   KMT2B     chr19        NM_014727      exon28   c.T6746G               p.V2249G               7.06                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   ERBB2     chr17        NM_004448      exon1    c.T25G                 p.W9G                  6.37                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   KMT2B     chr19        NM_014727      exon28   c.T6737G               p.V2246G               5.67                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   CREBBP    chr16        NM_004380      exon30   c.A4931C               p.N1644T               5.61                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   APC       chr5         NM_000038      exon16   c.G4057T               p.E1353X               5.57                                     COSM19048     0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   PTCH1     chr9         NM_000264      exon1    c.A26C                 p.E9A                  5.41                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   PTPRK     chr6         NM_002844      exon15   c.C2432T               p.T811I                5.39                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   TYMP      chr22        NM_001953      exon8    c.T941G                p.L314R                5.31                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   RB1       chr13        NM_000321      exon1    c.A24C                 p.K8N                  5.29                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0
  H1011   TYMP      chr22        NM_001953      exon9    c.T1175G               p.V392G                5.22                                                   0                                               0           0       0                                                        0           0       0                                                       0           0       0                                                    0           0

ALT, alteration.

[^1]: Contributed equally
